Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation.

International journal of medical sciences - 1 Jan 2024

Deng Qiuhua, Wang Fengnan, Song Lei, Chen Liangyu, Huang Ying, Guo Zhihua, Yang Haihong

Abstract excerpt

Introduction: Epidermal growth factor receptor (EGFR) mutation is common in Chinese patients with lung adenocarcinoma (LUAD). Brain metastases (BMs) is high and associated with poor prognosis. Identification of EGFR-mutant patients at high risk of developing BMs is important to reduce or delay the incidence of BMs. Currently, there is no literature on the prediction and modeling of EGFR brain metastasis at the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Chromatography, Liquid

Share to ErbB Receptors

Share to Neoplasm Recurrence, Local

Share to Proteomics

Share to Tandem Mass Spectrometry

Source

Open in PubMed Open full text

Identifiers

PMID: 38464823
DOI: 10.7150/ijms.92993
PMCID: PMC10920840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation.PMID 38464823Read ↗

Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR MutationSemantic proximity Read ↗

Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.Semantic proximity Read ↗

Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databasesSemantic proximity Read ↗

Proteomic characteristics of lung adenocarcinoma tumors that are small but highly invasiveSemantic proximity Read ↗

An immune-related gene expression signature predicts brain metastasis in lung adenocarcinoma patients after surgery: gene expression profile and immunohistochemical analysesSemantic proximity Read ↗

Advances in Lung Cancer Driver Genes Associated With Brain MetastasisSemantic proximity Read ↗

Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma.Semantic proximity Read ↗

Single-cell RNA Sequencing Analysis Identifies Key Genes in Brain Metastasis from Lung AdenocarcinomaSemantic proximity Read ↗

Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancerSemantic proximity Read ↗

An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC)Semantic proximity Read ↗

Comparative genome-wide analysis of hub lncRNAs and mRNAs in brain metastatic small cell lung cancer – An in-Silico ApproachSemantic proximity Read ↗

Brain parenchymal and leptomeningeal metastasis in lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.